Delivery Order SPE2DB25D3003-SPE2DB25FPVSP

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $21,162.03 firm fixed price contract is for the supply of ORENCIA CLICKJECT 125 MG/ML, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies for the provision of a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,648.46 firm fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty medication. The contract has an ultimate completion date of November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORENCIA CLICKJECT 125 MG/MLML. The contract has a firm fixed price of $39,688.42 and a completion date of August 1, 2024. The contract is not set aside for any specific business type. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,885.08 firm fixed price contract is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product, with a period of performance through February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,585.76 Firm Fixed Price Delivery Order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty medication. The contract has a completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $18,227.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products and has an ultimate completion date of December 31, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a Set-Aside contract. AmerisourceBergen holds a...
The Defense Logistics Agency (DLA) awarded a $7,001.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division to supply ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. The contract has an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $6,663.84 firm fixed price contract is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,969.27 firm fixed-price delivery order is for the procurement of ORENCIA CLICKJECT 125 MG/ML medical supplies. The contract has an ultimate completion date of February 4, 2025 and does not utilize any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the pharmaceutical product "ORENCIA CLICKJECT 125 MG/MLML". The contract has a ceiling value of $10,029.17 and is a firm fixed price delivery order. The ultimate completion date for this order is July 25, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this contract is part of the company's...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPVSP
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $22,902.18 and is for the delivery of ORENCIA CLICKJECT 125 MG/ML medical supplies. The contract is a Firm Fixed Price arrangement and is not set aside for any particular business type.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/5/25, 9:57 AM